Wetherby Asset Management Inc Amgen Inc Transaction History

Wetherby Asset Management Inc

$2.13 Billion
Q3 2024

A detailed history of Wetherby Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Wetherby Asset Management Inc holds 17,698 shares of AMGN stock, worth $4.68 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

17,698

Previous 17,654 0.25%

Holding current value

$4.68 Million

Previous $5.52 Million 3.39%

% of portfolio

0.27%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $13,612 - $14,844	44 Added 0.25%	17,698 $5.7 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $84,868 - $103,137	-323 Reduced 1.8%	17,654 $5.52 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $90,609 - $109,376	-337 Reduced 1.84%	17,977 $5.11 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $99,978 - $112,787	391 Added 2.18%	18,314 $5.27 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $103,202 - $128,129	472 Added 2.7%	17,923 $4.82 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $359,759 - $425,408	-1,679 Reduced 8.78%	17,451 $3.87 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $103,637 - $126,316	459 Added 2.46%	19,130 $4.62 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $65,502 - $83,228	286 Added 1.56%	18,671 $4.9 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $50,054 - $56,452	-223 Reduced 1.2%	18,385 $4.14 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $311,919 - $347,112	1,352 Added 7.83%	18,608 $4.53 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $205,017 - $226,802	935 Added 5.73%	17,256 $4.17 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $107,991 - $123,586	543 Added 3.44%	16,321 $3.67 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $300,362 - $351,910	-1,415 Reduced 8.23%	15,778 $3.36 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $430,020 - $477,076	1,841 Added 11.99%	17,193 $4.19 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $415,193 - $483,840	-1,871 Reduced 10.86%	15,352 $3.82 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $228,064 - $271,584	1,054 Added 6.52%	17,223 $3.96 Million
Q3 2020 Dec 16, 2020	SELL	$234.65 - $260.95 $348,220 - $387,249	-1,484 Reduced 8.41%	16,169 $4.11 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $287,915 - $320,185	1,227 Added 7.47%	17,653 $4.49 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $206,513 - $253,420	1,044 Added 6.79%	16,426 $3.88 Million
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $287,939 - $381,886	1,580 Added 11.45%	15,382 $3.12 Million
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $216,645 - $278,464	-1,145 Reduced 7.66%	13,802 $3.33 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $143,118 - $171,485	822 Added 5.82%	14,947 $2.89 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $41,508 - $48,657	-249 Reduced 1.73%	14,125 $2.6 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $100,021 - $112,745	-553 Reduced 3.7%	14,374 $2.73 Million
Q4 2018 Jan 30, 2019	BUY	$178.4 - $208.25 $1,605 - $1,874	9 Added 0.06%	14,927 $2.91 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $64,295 - $72,484	347 Added 2.38%	14,918 $3.09 Million
Q2 2018 Jul 24, 2018	SELL	$166.05 - $186.51 $68,578 - $77,028	-413 Reduced 2.76%	14,571 $2.69 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $45,576 - $53,262	269 Added 1.83%	14,984 $2.55 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $104,818 - $117,114	621 Added 4.41%	14,715 $2.56 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $2.36 Million - $2.69 Million	14,094	14,094 $2.63 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Amgen Inc Transaction History